Latest Science mRNA HIV vaccine candidate launches first-in-Africa study The nonprofit scientific research organization IAVI and Massachusetts-based Moderna, Inc. recently announced that a Phase I clinical trial of an mRNA HIV vaccine antigen (mRNA-1644) will soon launch at the Center for... 23 May, 20222 min read